BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. ✅
Journal of applied microbiology (J Appl Microbiol ) Vol: 100 Issue 6 Pages: 1324-32 Pub: 2006 Jun Epub: Authors Hütt P , Shchepetova J , Lõivukene K , Kullisaar T , Mikelsaar M , |
|
|
Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. ✅
Journal of applied microbiology (J Appl Microbiol ) Vol: 100 Issue 6 Pages: 1324-32 Pub: 2006 Jun Epub: Authors Hütt P , Shchepetova J , Lõivukene K , Kullisaar T , Mikelsaar M , |
|
|
Use of selected lactic acid bacteria in the eradication of Helicobacter pylori infection. ✅
Go to Publication ✅
Journal of microbiology (Seoul, Korea) (J Microbiol ) Vol: 52 Issue 11 Pages: 955-62 Pub: 2014 Nov Epub: 2014 Oct 3 Authors Kim JE , Kim MS , Yoon YS , Chung MJ , Yum DY , |
|
|
The protective potential of selected lactic acid bacteria against the most common contaminants in various types of cheese in Egypt. ✅
Go to Publication ✅
Heliyon (Heliyon ) Vol: 5 Issue 3 Pages: e01362 Pub: 2019 Mar Epub: 2019 Mar 19 Authors Al-Gamal MS , Ibrahim GA , Sharaf OM , Radwan AA , Dabiza NM , Youssef AM , El-Ssayad MF , |
|
|
The protective potential of selected lactic acid bacteria against the most common contaminants in various types of cheese in Egypt. ✅
Go to Publication ✅
Heliyon (Heliyon ) Vol: 5 Issue 3 Pages: e01362 Pub: 2019 Mar Epub: 2019 Mar 19 Authors Al-Gamal MS , Ibrahim GA , Sharaf OM , Radwan AA , Dabiza NM , Youssef AM , El-Ssayad MF , |
|
|
The protective potential of selected lactic acid bacteria against the most common contaminants in various types of cheese in Egypt. ✅
Go to Publication ✅
Heliyon (Heliyon ) Vol: 5 Issue 3 Pages: e01362 Pub: 2019 Mar Epub: 2019 Mar 19 Authors Al-Gamal MS , Ibrahim GA , Sharaf OM , Radwan AA , Dabiza NM , Youssef AM , El-Ssayad MF , |
|
|
Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats. ✅
Go to Publication ✅
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 103 Issue 23-24 Pages: 9673-9686 Pub: 2019 Dec Epub: 2019 Nov 12 Authors Wang Q , Lv L , Jiang H , Wang K , Yan R , Li Y , Ye J , Wu J , Wang Q , Bian X , Yang L , Jiang X , Xie J , Lu Y , Shen J , Li L , |
|
|
Bifidobacterium longum subsp. longum 51A attenuates intestinal injury against irinotecan-induced mucositis in mice. ✅
Go to Publication ✅
Life sciences (Life Sci ) Vol: 289 Issue Pages: 120243 Pub: 2022 Jan 15 Epub: 2021 Dec 16 Authors Quintanilha MF , Miranda VC , Souza RO , Gallotti B , Cruz C , Santos EA , Alvarez-Leite JI , Jesus LCL , Azevedo V , Trindade LM , Cardoso VN , Ferreira E , Carvalho BA , Soares PMG , Vieira AT , Nicoli JR , Martins FS , |
|
|
Lactobacillus sp. improved microbiota and metabolite profiles of aging rats. ✅
Go to Publication ✅
Pharmacological research (Pharmacol Res ) Vol: 146 Issue Pages: 104312 Pub: 2019 Aug Epub: 2019 Jun 14 Authors Hor YY , Lew LC , Jaafar MH , Lau AS , Ong JS , Kato T , Nakanishi Y , Azzam G , Azlan A , Ohno H , Liong MT , |
|
|
Health-Promoting Properties of Lactobacillus helveticus. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 3 Issue Pages: 392 Pub: 2012 Epub: 2012 Nov 19 Authors Taverniti V , Guglielmetti S , |
|
|
Health-Promoting Properties of Lactobacillus helveticus. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 3 Issue Pages: 392 Pub: 2012 Epub: 2012 Nov 19 Authors Taverniti V , Guglielmetti S , |
|
|
Health-Promoting Properties of Lactobacillus helveticus. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 3 Issue Pages: 392 Pub: 2012 Epub: 2012 Nov 19 Authors Taverniti V , Guglielmetti S , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
